Feasibility Assessment of Using the MiToS Staging System for Conducting Economic Evaluation in Amyotrophic Lateral Sclerosis

Time From Amyotrophic Lateral Sclerosis Symptom Onset to Key Disease Milestones: Analysis of Data From a Multinational Cross-Sectional Survey

Increase in HCM-Related Economic Burden Due to Atrial Fibrillation in Patients with Symptomatic Obstructive Hypertrophic Cardiomyopathy: A Claims Analysis of 9490 Patients

An Evidence Gap Analysis of the Epidemiology and Burden of Obstructive Hypertrophic Cardiomyopathy

Logistic and Economic Burden of Non-Obstructive Hypertrophic Cardiomyopathy – Results From Medical and Pharmacy Claims Data

Healthcare Resource Utilization and Economic Burden Due to Atrial Fibrillation in Symptomatic Obstructive Hypertrophic Cardiomyopathy: Real-World Analysis of 2016-2021 Claims Data

Differences in Healthcare Resource Use and Cost by Treatment Choice Among Patients with Symptomatic Obstructive Hypertrophic Cardiomyopathy: Real-World Analysis of 2016-2021 Claims Data

Cardiovascular Hospitalizations post Septal Myectomy for Obstructive Hypertrophic Cardiomyopathy: A 3-Year Analysis of 5,101 Patients

Symptoms and Complications Significantly Increase the Logistic and Economic Burden of Obstructive Hypertrophic Cardiomyopathy – Results From Medical and Pharmacy Claims Data

Characteristics and Procedural Complications of Septal Myectomy for Obstructive Hypertrophic Cardiomyopathy in the United States